This chapter delves into the prevalence and difficulties surrounding endometriosis, emphasizing the lack of understanding and funding compared to other illnesses. It highlights a groundbreaking clinical trial at the University of Edinburgh targeting lactate levels in the pelvis, offering hope for improved treatment outcomes for women with endometriosis.
Some within China might prefer another Donald Trump presidency while others might favour Joe Biden. On balance, though: from there, neither option looks great. We look at the steps toward the first drug in four decades to treat the debilitating disease of endometriosis (9:28). And as the word podcasting turns 20 we reflect on a medium close to our hearts (17:51).
Get a world of insights for 50% off—subscribe to Economist Podcasts+
If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription. For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.